| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |